Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
AN2 Therapeutics, Inc. (ANTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
18 Jan 2024
Zakrzewski Joseph S
Director
AN2 Therapeutics, Inc.
(ANTX)
405,880
-19%
100,000
$19.11
$1,911,410.00
SELL
16 Jan 2024
Aziz Kabeer
Director
AN2 Therapeutics, Inc.
(ANTX)
1,995,958
-4%
100,000
$19.65
$1,964,999.90
SELL
16 Jan 2024
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
1,995,958
-4%
100,000
$19.65
$1,964,999.90
SELL
12 Jan 2024
Readnour Robin Shane
Director
AN2 Therapeutics, Inc.
(ANTX)
414,788
-0%
1,425
$21.91
$31,228.81
SELL
10 Jan 2024
Readnour Robin Shane
Director
AN2 Therapeutics, Inc.
(ANTX)
415,494
-0%
3,669
$21.93
$80,443.17
SELL
9 Jan 2024
Krause Kevin Michael
Chief Strategy Officer, Officer
AN2 Therapeutics, Inc.
(ANTX)
1,914
-79%
7,417
$20.14
$149,367.25
SELL
2 Jan 2024
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
2,130
-56%
2,777
$20.09
$55,802.43
SELL
2 Jan 2024
Krause Kevin Michael
Chief Strategy Officer, Officer
AN2 Therapeutics, Inc.
(ANTX)
1,914
-57%
2,583
$20.12
$51,967.12
SELL
14 Nov 2023
Aziz Kabeer
Director, 10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,080,051
-0%
1,810
$16.15
$29,224.26
SELL
14 Nov 2023
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,080,051
-0%
1,810
$16.15
$29,224.26
SELL
23 Aug 2023
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,183,888
-0%
400
$16.00
$6,400.00
SELL
23 Aug 2023
Aziz Kabeer
Director, 10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,183,888
-0%
400
$16.00
$6,400.00
SELL
23 Aug 2023
Aziz Kabeer
Director, 10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,177,883
-0%
7,140
$16.03
$114,484.14
SELL
23 Aug 2023
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,177,883
-0%
7,140
$16.03
$114,484.14
SELL
23 Aug 2023
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,177,547
-0%
400
$16.00
$6,400.00
SELL
23 Aug 2023
Aziz Kabeer
Director, 10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,177,547
-0%
400
$16.00
$6,400.00
BUY
18 Aug 2023
RA CAPITAL MANAGEMENT, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
5,135,683
+52%
1,777,778
$9.00
$16,000,002.00
SELL
10 Nov 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
4,907
-47%
4,436
$15.32
$67,974.27
SELL
8 Nov 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
4,907
-77%
17,166
$15.60
$267,793.62
SELL
3 Nov 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
6,943
-83%
35,196
$15.86
$558,274.00
SELL
31 Oct 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
4,907
-46%
4,232
$15.27
$64,625.20
SELL
27 Oct 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
4,907
-34%
2,607
$15.18
$39,582.39
SELL
24 Oct 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
4,907
-65%
9,350
$15.76
$147,357.73
SELL
20 Oct 2022
Easom Eric
Chief Executive Officer, Director, Officer
AN2 Therapeutics, Inc.
(ANTX)
7,257
-74%
21,244
$16.47
$349,911.80
BUY
26 Jul 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
3,771,608
+0%
23,219
$7.78
$180,674.69
BUY
21 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
3,748,389
+0%
302
$7.99
$2,412.98
BUY
13 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
3,748,087
+2%
81,424
$7.95
$647,401.90
BUY
29 Mar 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
3,251,051
+105%
1,666,666
$15.00
$24,999,992.00
BUY
29 Mar 2022
Aziz Kabeer
Director, 10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,210,735
+8%
166,666
$15.00
$2,499,990.00
BUY
29 Mar 2022
Adjuvant Global Health Technology Fund, L.P.
10% Owner
AN2 Therapeutics, Inc.
(ANTX)
2,210,735
+8%
166,666
$15.00
$2,499,990.00
BUY
29 Mar 2022
Readnour Robin Shane
Director
AN2 Therapeutics, Inc.
(ANTX)
417,363
+58%
153,334
$15.00
$2,300,010.00
Home